Literature DB >> 29496501

Geographic Variability in Liver Disease-Related Mortality Rates in the United States.

Archita P Desai1, Prashanthinie Mohan2, Anne M Roubal2, Ricki Bettencourt3, Rohit Loomba4.   

Abstract

PURPOSE: Liver disease is an important cause of morbidity and mortality in the United States. Geographic variations in the burden of chronic liver disease may have significant impact on public health policies but have not been explored at the national level. The objective of this study is to examine interstate variability in liver disease mortality in the United States.
METHODS: We compared liver disease mortality from the 2010 National Vital Statistics Report on a state level. States in each quartile of liver disease mortality were compared with regard to viral hepatitis death rates, alcohol consumption, obesity, ethnic and racial composition, and household income. Race, ethnicity, and median household income data were derived from the 2010 US Census. Alcohol consumption and obesity data were obtained from the 2010 Behavioral Risk Factor Surveillance System Survey. RESULTS AND
CONCLUSION: We found significant interstate variability in liver disease mortality, ranging from 6.4 to 17.0 per 100,000. The South and the West carry some of the highest rates of liver disease mortality. In addition to viral hepatitis death rates, there is a strong correlation between higher percentage of Hispanic population and a state's liver disease mortality rate (r = 0.538, P < .001). Lower household income (r = 0.405, P = .003) was also associated with the higher liver disease mortality. While there was a trend between higher obesity rates and higher liver disease mortality, the correlation was not strong and there was no clear association between alcohol consumption and liver disease mortality rates.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Death; Geographic variability; Liver disease; Population-based factors

Mesh:

Year:  2018        PMID: 29496501      PMCID: PMC6090542          DOI: 10.1016/j.amjmed.2018.01.047

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

Review 1.  Current and Future Burden of Chronic Nonmalignant Liver Disease.

Authors:  Prowpanga Udompap; Donghee Kim; W Ray Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-17       Impact factor: 11.382

2.  Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study.

Authors:  George Howard; Ron Prineas; Claudia Moy; Mary Cushman; Martha Kellum; Ella Temple; Andra Graham; Virginia Howard
Journal:  Stroke       Date:  2006-03-23       Impact factor: 7.914

3.  U.S. mortality from liver cirrhosis and alcoholic liver disease in 1999-2004: regional and state variation in relation to per capita alcohol consumption.

Authors:  Anthony P Polednak
Journal:  Subst Use Misuse       Date:  2012-02       Impact factor: 2.164

4.  Addressing geographic disparities in liver transplantation through redistricting.

Authors:  S E Gentry; A B Massie; S W Cheek; K L Lentine; E H Chow; C E Wickliffe; N Dzebashvili; P R Salvalaggio; M A Schnitzler; D A Axelrod; D L Segev
Journal:  Am J Transplant       Date:  2013-07-09       Impact factor: 8.086

Review 5.  Chronic liver disease in the Hispanic population of the United States.

Authors:  Andres F Carrion; Ravi Ghanta; Olveen Carrasquillo; Paul Martin
Journal:  Clin Gastroenterol Hepatol       Date:  2011-05-12       Impact factor: 11.382

6.  ACCESS: acute cerebrovascular care in emergency stroke systems.

Authors:  Karen C Albright; Charles C Branas; Brett C Meyer; Dawn E Matherne-Meyer; Justin A Zivin; Patrick D Lyden; Brendan G Carr
Journal:  Arch Neurol       Date:  2010-10

7.  Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption.

Authors:  G K Singh; D L Hoyert
Journal:  Hum Biol       Date:  2000-10       Impact factor: 0.553

8.  Underestimation of liver-related mortality in the United States.

Authors:  Sumeet K Asrani; Joseph J Larson; Barbara Yawn; Terry M Therneau; W Ray Kim
Journal:  Gastroenterology       Date:  2013-04-09       Impact factor: 22.682

9.  Deaths: leading causes for 2010.

Authors:  Melonie Heron
Journal:  Natl Vital Stat Rep       Date:  2013-12-20

10.  Geographic variations in cardiovascular health in the United States: contributions of state- and individual-level factors.

Authors:  Samson Y Gebreab; Sharon K Davis; Jürgen Symanzik; George A Mensah; Gary H Gibbons; Ana V Diez-Roux
Journal:  J Am Heart Assoc       Date:  2015-05-27       Impact factor: 5.501

View more
  5 in total

1.  PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample.

Authors:  Trang VoPham; Nicole J Kim; Kristin Berry; Jason A Mendoza; Joel D Kaufman; George N Ioannou
Journal:  Environ Res       Date:  2022-06-07       Impact factor: 8.431

2.  Mortality from liver cirrhosis and HCC in the DAA era: success in viral control is darkened by raise of metabolic disease.

Authors:  Antonio Saviano; Thomas F Baumert
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 8.265

3.  Trends and Outcomes of Alcoholic Liver Cirrhosis Hospitalizations in the Last Two Decades: Analysis of the Nationwide Inpatient Sample.

Authors:  Hisham Laswi; Abdul-Rahman Abusalim; Muhammad Sheharyar Warraich; Katayoun Khoshbin; Hafeez Shaka
Journal:  Gastroenterology Res       Date:  2022-04-23

4.  Textbook Outcome as a Quality Metric in Liver Transplantation.

Authors:  Austin D Schenk; Jing L Han; April J Logan; Jeffrey M Sneddon; Guy N Brock; Timothy M Pawlik; William K Washburn
Journal:  Transplant Direct       Date:  2022-04-15

Review 5.  Cell and Tissue Therapy for the Treatment of Chronic Liver Disease.

Authors:  Yaron Bram; Duc-Huy T Nguyen; Vikas Gupta; Jiwoon Park; Chanel Richardson; Vasuretha Chandar; Robert E Schwartz
Journal:  Annu Rev Biomed Eng       Date:  2021-05-11       Impact factor: 9.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.